Activin Receptor-Like Kinases: A Diverse Family Playing An Important Role In Cancer

Keywords

Activin; BMP; Targeted therapy; TGFβ

Abstract

The role and function of the members of the TGFβ superfamily has been a substantial area of research focus for the last several decades. During that time, it has become apparent that aberrations in TGFβ family signaling, whether through the BMP, Activin, or TGFβ arms of the pathway, can result in tumorigenesis or contribute to its progression. Downstream signaling regulates cellular growth under normal physiological conditions yet induces diverse processes during carcinogenesis, ranging from epithelial- to-mesenchymal transition to cell migration and invasion to angiogenesis. Due to these observations, the question has been raised how to utilize and target components of these signaling pathways in cancer therapy. Given that these cascades include both ligands and receptors, there are multiple levels at which to interfere. Activin receptor-like kinases (ALKs) are a group of seven type I receptors responsible for TGFβ family signal transduction and are utilized by many ligands within the superfamily. The challenge lies in specifically targeting the often-overlapping functional effects of BMP, Activin, or TGFβ signaling during cancer progression. This review focuses on the characteristic function of the individual receptors within each subfamily and their recognized roles in cancer. We next explore the clinical utility of therapeutically targeting ALKs as some have shown partial responses in Phase I clinical trials but disappointing outcomes when used in Phase II studies. Finally, we discuss the challenges and future directions of this body of work.

Publication Date

1-1-2016

Publication Title

American Journal of Cancer Research

Volume

6

Issue

11

Number of Pages

2431-2447

Document Type

Editorial Material

Personal Identifier

scopus

Socpus ID

85007195969 (Scopus)

Source API URL

https://api.elsevier.com/content/abstract/scopus_id/85007195969

This document is currently not available here.

Share

COinS